Učitavanje...
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
BACKGROUND: Immune checkpoint inhibitors (ICPIs), used to treat different advanced malignancies, are associated with a wide range of immune-related adverse reactions (irAEs) that deserve close monitoring of patients. Gastrointestinal reactions and hepatotoxicity may occur, which warrant careful eval...
Spremljeno u:
| Izdano u: | J Immunother Cancer |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380028/ https://ncbi.nlm.nih.gov/pubmed/30777137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0532-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|